Anticoagulation therapy using rh-thrombomodulin and/or antithrombin III agent is associated with reduction in in-hospital mortality in septic disseminated intravascular coagulation: a nationwide registry study - Tanaka, K; Takeba, J; Matsumoto, H (Shock, 2019)